Riancho, J.A.; Hernández, J.L.; González-Vela, C.; López-Sundh, A.E.; González-Lopez, M.A.; Gomez de la Fuente, F.; Quirce, R.; Diamond, E.L.
Erdheim–Chester Disease Due to a Novel Internal Duplication of NRAS: Response to Targeted Therapy with Cobimetinib. Int. J. Mol. Sci. 2023, 24, 15467.
https://doi.org/10.3390/ijms242015467
AMA Style
Riancho JA, Hernández JL, González-Vela C, López-Sundh AE, González-Lopez MA, Gomez de la Fuente F, Quirce R, Diamond EL.
Erdheim–Chester Disease Due to a Novel Internal Duplication of NRAS: Response to Targeted Therapy with Cobimetinib. International Journal of Molecular Sciences. 2023; 24(20):15467.
https://doi.org/10.3390/ijms242015467
Chicago/Turabian Style
Riancho, José A., José L. Hernández, Carmen González-Vela, Ana E. López-Sundh, Marcos A. González-Lopez, Francisco Gomez de la Fuente, Remedios Quirce, and Eli L. Diamond.
2023. "Erdheim–Chester Disease Due to a Novel Internal Duplication of NRAS: Response to Targeted Therapy with Cobimetinib" International Journal of Molecular Sciences 24, no. 20: 15467.
https://doi.org/10.3390/ijms242015467
APA Style
Riancho, J. A., Hernández, J. L., González-Vela, C., López-Sundh, A. E., González-Lopez, M. A., Gomez de la Fuente, F., Quirce, R., & Diamond, E. L.
(2023). Erdheim–Chester Disease Due to a Novel Internal Duplication of NRAS: Response to Targeted Therapy with Cobimetinib. International Journal of Molecular Sciences, 24(20), 15467.
https://doi.org/10.3390/ijms242015467
